Valuation: Zalicus Inc

Market Cap 746K 655K 607K 558K 1.05M 71.81M 1.07M 7.24M 2.83M 35.19M 2.8M 2.74M 122M P/E 2014
-0.83x
P/E 2015 -1.35x
Enterprise Value -15.94M -13.98M -12.95M -11.91M -22.48M -1.53B -22.77M -155M -60.44M -751M -59.82M -58.53M -2.6B EV / Sales 2014
14,770,294,750x
EV / Sales 2015 83,658,631x
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%-4.18%-1.02%+2.10% 48.71B
+1.61%-0.36%+378.56%+583.41% 38.35B
+2.61%+4.84%+8.19%+65.22% 34.53B
-1.12%-2.86%+25.52%-10.93% 34.03B
-0.58%-2.00%-0.07%+31.08% 26.77B
+1.37%-3.78% - - 15.64B
+0.71%+0.28%+70.48%+115.34% 15.08B
-2.03%+0.23%+13.53%+15.87% 14.18B
+0.26%+0.31%+16.08%-32.65% 12.73B
Average +0.29%-1.04%+63.91%+96.18% 26.67B
Weighted average by Cap. +0.40%-1.36%+76.11%+119.16%

Financials

2014 2015
Net sales 0 0 0 0 0.01 0.38 0.01 0.04 0.02 0.19 0.02 0.01 0.65 0.7 0.61 0.57 0.52 0.99 67.45 1 6.8 2.66 33.05 2.63 2.57 114.4
Net income -41.84M -36.71M -34.01M -31.28M -59.03M -4.03B -59.78M -406M -159M -1.97B -157M -154M -6.83B -52.19M -45.78M -42.42M -39.02M -73.62M -5.02B -74.56M -506M -198M -2.46B -196M -192M -8.52B
Net Debt -14.18M -12.44M -11.53M -10.6M -20M -1.36B -20.26M -138M -53.78M -669M -53.23M -52.08M -2.31B -16.68M -14.63M -13.56M -12.47M -23.53M -1.61B -23.83M -162M -63.27M -787M -62.62M -61.27M -2.72B
Logo Zalicus Inc
EPIRUS Biopharmaceuticals Inc is a United States-based company. The Company operates as a pharmaceutical preparation manufacturer.
Employees
-